Elevance Health, Inc. (ELV)
| Market Cap | 89.36B |
| Revenue (ttm) | 174.02B |
| Net Income (ttm) | 6.42B |
| Shares Out | 231.92M |
| EPS (ttm) | 27.42 |
| PE Ratio | 14.05 |
| Forward PE | 11.72 |
| Dividend | $6.52 (1.69%) |
| Ex-Dividend Date | Dec 5, 2024 |
| Volume | 1,715,669 |
| Open | 387.02 |
| Previous Close | 385.26 |
| Day's Range | 383.83 - 389.87 |
| 52-Week Range | 362.21 - 567.26 |
| Beta | 0.85 |
| Analysts | Strong Buy |
| Price Target | 540.21 (+40.21%) |
| Earnings Date | Jan 23, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates i... [Read more]
Financial Performance
In 2023, Elevance Health's revenue was $171.34 billion, an increase of 9.41% compared to the previous year's $156.60 billion. Earnings were $5.99 billion, an increase of 1.58%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for ELV stock is "Strong Buy." The 12-month stock price forecast is $540.21, which is an increase of 40.21% from the latest price.
News
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management ...
My Top 15 High Growth Dividend Stocks For January 2025
The SPDR S&P 500 ETF Trust ended 2024 on a sour note, losing 2.41% in December and finishing the year up 24.89%. The Top 15 dividend growth stocks for January 2025 offer an average dividend yield of 1...
Elevance Health Is An Undervalued Healthcare Juggernaut
Elevance Health is a strong buy despite a 30% stock decline, due to its solid fundamentals and market position in the health insurance industry. The company benefits from secular trends like an aging ...
Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance He...
Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fiduciary Duties Owed to Shareholders
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors vi...
Senators Warren and Hawley introduce a bipartisan bill to break up pharmacy-benefit managers
CNBC's Bertha Coombs joins ‘The Exchange' to discuss a bipartisan bill introduced by Senators Elizabeth Warren and Josh Hawley aimed at breaking up pharmacy-benefit managers.
Health care stocks fall as lawmakers, patients push for changes to their business models
Shares of major healthcare companies fell nearly 5% on Wednesday on concerns related to potential changes to their complex business models. That includes UnitedHealth Group, Cigna and CVS Health, whic...
Health insurer stocks fall as WSJ says lawmakers set to break up pharmacy-benefit managers
Shares of health insurers such as UnitedHealth and CVS Health fell on Wednesday after a Wall Street Journal report said a bipartisan group of lawmakers were set to introduce legislation to break up ph...
Elevance Health: A Quality Underpriced Stock Returning To Health
Elevance Health has shown robust financial performance, with a 9.1% revenue CAGR and 13.7% EPS growth over the past decade. Despite recent share price weakness, ELV's long-term fundamentals remain str...
UnitedHealth, rival insurer stocks continue to tumble after Brian Thompson's murder in NYC
Thompson's death sparked a wide social media conversation over frustrations with navigating the US health insurance system.
Health insurer shares fall after UnitedHealth exec murder
Shares of health insurance companies including UnitedHealth Group continued to fall on Friday, two days after Brian Thompson, the CEO of the company's health insurance unit, was fatally shot outside a...
Health Insurance Stocks—Led By UnitedHealth—Suffer Steep Drops Following Brian Thompson's Killing
Shares of UnitedHealthcare's parent company led a broader selloff in health insurance stocks, losses one analyst described as a likely result of the industry's fresh focus following the Wednesday kill...
Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy, Announces Reversal
When Anthem Blue Cross Blue Shield said it will no longer pay for anesthesia care if the surgery or procedure exceeds an arbitrary time limit, parent company Elevance Health Inc ELV faced backlash and...
Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securi...
My Top 15 High-Growth Dividend Stocks For December 2024
The SPDR S&P 500 ETF Trust posted a strong gain of 5.96% in November, resuming its strong run in 2024. The Top 15 dividend growth stocks for December 2024 offer an average dividend yield of 1.2% and a...
Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript)
Elevance Health, Inc. (NYSE:ELV) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J.
Trump Win Gives Some U.S. Health Insurers A Post-Election Bump On Wall Street
Several US health insurers saw notable stock price gains following the reelection of former US President Donald Trump amid an expectation of less federal scrutiny. Humana Inc. experienced the largest ...
Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others viola...
Elevance Health Announces Appearance at UBS Global Healthcare Conference
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on ...
Elevance Health Appoints Nathan Rich Vice President, Investor Relations
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich wil...
My Top 15 High-Growth Dividend Stocks For November 2024
The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% an...
Elevance Health Foundation Names Professional Football Player Ryan Kelly as Next Elevance Health Champion
INDIANAPOLIS--(BUSINESS WIRE)-- #maternalhealth--The Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces professional football player Ryan Kelly as its latest Elevanc...
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Bonds
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $350 million, 4.5% se...
'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.